条状胆固醇内神经元的同步激活会诱导局部的血清释放
Lior Matityahu1, Zachary B Hobel2, Noa Berkowitz1
1Department of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of the Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel.
bioRxiv : the preprint server for biology
|November 18, 2024
概括
条状胆固醇内神经元 (CIN) 的同步激活会触发血清的释放,类似于多巴胺. 这种机制在强迫症类似行为的小鼠模型中得到了放大,突出了CINs.
科学领域:
- 神经科学是一个神经科学.
- 神经生物学 神经生物学 神经生物学
- 条形电路的电路结构.
背景情况:
- 已知状胆固醇内部神经元 (CINs) 通过激活多巴胺轴突上的尼古丁乙胆受体来调节多巴胺释放.
- 通过CINs影响其他神经递质系统,特别是血清素的确切机制仍然不太清楚.
研究的目的:
- 研究同步CIN激活在调节条体内局部血清释放中的作用.
- 为了确定这种CIN介导的血清素释放机制是否在与高胆固醇状态相关的病理条件中发生变化,例如强迫症 (OCD) 类似的行为.
主要方法:
- 利用小鼠状体中的体内电生理学记录来监测神经递质释放.
- 采用光遗传或化学遗传刺激技术来选择性地激活CINs.
- 在野生类型和转基因小鼠模型中分析神经递质动态对CIN激活的反应.
主要成果:
- 发现同步激活CINs可诱导和扩大条体中局部色胺释放的范围.
- 这种由CIN驱动的血清释放机制通过涉及尼古丁性乙胆受体的途径运作,类似于它对多巴胺的影响.
- 通过CINs诱导和释放血清的程度在表现出强迫症类行为的小鼠模型的高胆性条纹体中显著夸大.
结论:
- CINs在通过尼古丁性乙胆受体依赖机制调节局部条纹性血清释放方面发挥着关键作用.
- 这种CIN-色素通路的调节失调可能有助于具有高胆固醇活性和变化的条状功能特征的疾病的病理生理学,如强迫症.
- 这些发现确定了CINs作为健康和患病的条纹体中多巴胺和血清激素信号传递的关键调节者.
更多相关视频
相关概念视频
Cholinergic Neurons: Neurotransmission
2.6K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
2.6K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
212
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
212
Drugs Affecting Neurotransmitter Release or Uptake
954
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
954
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
618
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
618


